Clinical Trial

The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This trial will evaluate the efficacy and safety of HRS-4029 compared with placebo in participants with acute ischemic stroke (AIS).
Trial Details
NCT Number NCT07739160
Lead Sponsor Beijing Suncadia Pharmaceuticals Co., Ltd
Conditions Acute Ischemic Stroke
Enrollment 340 participants
Start Date 2026-08-15
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-31